China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999):企業の財務・戦略的SWOT分析

◆英語タイトル:China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C7724
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

China Resources Sanjiu Medical & Pharmaceutical Co Ltd (Sanjiu) a subsidiary of China Resources (Holdings) Co., Ltd. researches and develops, manufactures and commercializes pharmaceutical products including traditional Chinese medicine OTC and prescription drugs. Sanjiu’s product portfolio comprises OTC drugs, antibiotic drugs and active pharmaceutical ingredients (APIs), Chinese prescription medicines and traditional Chinese medicine (TCM) and formula granules. The company offers its products under 999 brand and Sanjiuweitai series. It also provides packaging, printing, international trade business and other services. The company has presence throughout China and also exports to the overseas markets. Sanjiu is headquartered in Shenzhen, China.

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Key Recent Developments

Jun 26,2017: China Resources Sanjiu Medical & Pharma elects new chairman

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – Key Facts 6
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – Key Employees 7
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – Major Products and Services 8
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – History 9
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – Company Statement 11
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 14
Company Overview 14
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – Business Description 15
Business Segment: Others 15
Performance 15
Business Segment: Overseas Trade 15
Overview 15
Performance 15
Business Segment: Packaging and printing 15
Overview 15
Performance 15
Business Segment: Pharmaceutical Industry 15
Overview 15
Performance 15
R&D Overview 16
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – Corporate Strategy 17
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – SWOT Analysis 18
SWOT Analysis – Overview 18
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – Strengths 18
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – Weaknesses 19
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – Opportunities 20
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – Threats 21
China Resources Sanjiu Medical & Pharmaceutical Co Ltd – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios – Interim Ratios 28
Financial Ratios – Ratio Charts 29
Section 4 – Company’s Lifesciences Financial Deals and Alliances 30
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Recent Deals Summary 32
Section 5 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Key Facts 6
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Key Employees 7
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Major Products and Services 8
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, History 9
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Subsidiaries 12
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Key Competitors 22
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Ratios based on current share price 23
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Annual Ratios 24
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 25
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Annual Ratios (Cont...2) 26
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Interim Ratios 28
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Recent Deals Summary 32
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36

List of Figures
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Performance Chart (2013 - 2017) 27
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Ratio Charts 29
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

★海外企業調査レポート[China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Takuma Co Ltd (6013):企業の財務・戦略的SWOT分析
    Takuma Co Ltd (6013) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Irish Life Assurance plc:企業の戦略・SWOT・財務分析
    Irish Life Assurance plc - Strategy, SWOT and Corporate Finance Report Summary Irish Life Assurance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Karyopharm Therapeutics Inc (KPTI):企業の財務・戦略的SWOT分析
    Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Lithia Motors, Inc.:企業のM&A・事業提携・投資動向
    Lithia Motors, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lithia Motors, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Carmat SAS (ALCAR)-医療機器分野:企業M&A・提携分析
    Summary Carmat SAS (Carmat) is a medical equipment company that offers artificial organs. The company offers development of innovative artificial organs, artificial heart and other vital organs. Its artificial heart products consists of an implantable heart, and components which help connect to an e …
  • Qvella Corp:医療機器:M&Aディール及び事業提携情報
    Summary Qvella Corp (Qvella) is a molecular diagnostics company which develops differentiated technology for rapid detection of pathogens causing Sepsis by direct sampling of bodily fluids. Its Field Activated Sample Treatment (FAST) -ID technology utilizes a novel electrical lysing and sample treat …
  • XL-protein GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary XL-protein GmbH (XL-protein) is a biopharmaceutical company that develops second generation biopharmaceutical drugs. The company develops PASylation technology, designed to enable the biopharmaceuticals drug development with extended plasma half-life and enhanced action. It provides its tech …
  • Crrc Corporation Limited
    Crrc Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Crrc Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Oshkosh Corporation:企業の戦略・SWOT・財務情報
    Oshkosh Corporation - Strategy, SWOT and Corporate Finance Report Summary Oshkosh Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Arabian Bemco Contracting Co. Ltd.
    Arabian Bemco Contracting Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arabian Bemco Contracting Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • USG Corporation:企業の戦略・SWOT・財務情報
    USG Corporation - Strategy, SWOT and Corporate Finance Report Summary USG Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Salem Media Group, Inc.:企業の戦略・SWOT・財務情報
    Salem Media Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Salem Media Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bioverativ Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technolog …
  • Bajaj Corp Limited:戦略・SWOT・企業財務分析
    Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • IBIDEN Co Ltd (4062):企業の財務・戦略的SWOT分析
    IBIDEN Co Ltd (4062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ALSO Holding AG:企業の戦略・SWOT・財務情報
    ALSO Holding AG - Strategy, SWOT and Corporate Finance Report Summary ALSO Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Medikit Co Ltd (7749):企業の製品パイプライン分析
    Summary Medikit Co Ltd (Medikit) is a medical equipment provider that offers vascular devices. The company offers IV catheter, hemodialysis and intervention products. Its products include supercath Z3V, supercath 5 safety IV catheter, supercath AZ, supercath CLS, i-works, seiha, parent plus, parent …
  • SP Transmission plc:企業の戦略的SWOT分析
    SP Transmission plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Immunovia AB (IMMNOV):企業の財務・戦略的SWOT分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • Mitsui E&S Holdings Co., Ltd. (7003):電力:M&Aディール及び事業提携情報
    Summary Mitsui E&S Holdings Co., Ltd. (Mitsui E&S) is a shipbuilding and engineering product manufacturing company. It has diversified business operations comprising environment recycling, construction of social infrastructure, advanced machinery systems, IT-related activities, ships and oceans, pla …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆